Article Versions Notes

Urkon M, Ferencz E, Szász JA, Szabo MIM, Orbán-Kis K, Szatmári S, Nagy EE. Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer’s Disease. Pharmaceuticals. 2025; 18(5):614. https://doi.org/10.3390/ph18050614

Urkon, Melinda, Elek Ferencz, József Attila Szász, Monica Iudita Maria Szabo, Károly Orbán-Kis, Szabolcs Szatmári, and Előd Ernő Nagy. 2025. "Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer’s Disease" Pharmaceuticals 18, no. 5: 614. https://doi.org/10.3390/ph18050614

Urkon, M., Ferencz, E., Szász, J. A., Szabo, M. I. M., Orbán-Kis, K., Szatmári, S., & Nagy, E. E. (2025). Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer’s Disease. Pharmaceuticals, 18(5), 614. https://doi.org/10.3390/ph18050614